Comparison of Pain Relief After Arthroscopic Knee Surgery: Adductor Canal Block and Genicular Nerve Block
Launched by BAŞAKŞEHIR ÇAM & SAKURA CITY HOSPITAL · Mar 27, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two methods of pain relief after arthroscopic knee surgery, which is a type of surgery performed with small incisions and special tools. The trial compares two techniques: the Adductor Canal Block (ACB) and the Genicular Nerve Block (GNB) to see which one works better in reducing pain after surgery. The main goal is to find out which method helps patients experience less pain, use fewer opioids (strong pain medications), and feel more satisfied with their pain management after surgery.
To participate in this study, individuals must be between 18 and 72 years old and scheduled for arthroscopic knee surgery. They also need to be able to agree to participate and not have any serious health issues that would prevent them from receiving regional anesthesia, which numbs a specific area of the body. Participants can expect to have their pain levels measured at various times after surgery, along with how much medication they need and their overall satisfaction with the pain relief methods. It’s important to note that both methods are designed to help relieve pain effectively, so participants will receive appropriate care regardless of which technique is found to be better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Voluntary willingness to participate in the study.
- • Patients undergoing arthroscopic knee surgery (meniscus, ACL, arthroscopic intervention etc).
- • ASA I-II-III classification.
- • Aged between 18-72 years.
- • No contraindications for regional anesthesia, and deemed suitable for regional anesthesia by the anesthesiologist.
- • Undergoing surgery under spinal anesthesia.
- • Fully oriented and able to cooperate.
- Exclusion Criteria:
- • Undergoing surgery under general anesthesia.
- • Chronic analgesic use.
- • Presence of an active infection at the procedure site.
- • Outside the appropriate age range.
- • Inability to comply with postoperative pain/NRS follow-ups.
- • ASA IV-V classification.
- • Non-voluntary patients.
- • Pregnancy.
About Başakşehir çam & Sakura City Hospital
Başakşehir Çam & Sakura City Hospital is a leading healthcare institution in Turkey, renowned for its state-of-the-art facilities and commitment to patient-centered care. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation across various therapeutic areas. With a multidisciplinary team of experts and a focus on ethical practices, Başakşehir Çam & Sakura City Hospital actively collaborates with industry partners and academic institutions to facilitate cutting-edge clinical trials, aiming to improve treatment outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İ̇stanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported